Complement-Mediated Postpartum Atypical Hemolytic Uremic Syndrome With Collapsing Focal Segmental Glomerulosclerosis
Rossella Piras1, Carolina Martinatto1, Elena Bresin1
1Clinical Research Center for Rare Diseases "Aldo e Cele Daccò," Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy.
Thrombotic microangiopathies (TMAs) that occur during pregnancy or the postpartum period-including preeclampsia/HELLP syndrome (hemolysis, elevated liver enzymes, low platelets), thrombotic thrombocytopenic purpura, and atypical hemolytic uremic syndrome (aHUS)-present a diagnostic challenge owing to their overlapping clinical features. We report a case of a 21-year-old primigravida of African origin who developed HELLP syndrome followed by postpartum aHUS. The clinical course was marked by thrombocytopenia, hemolytic anemia, acute kidney injury, and massive proteinuria. Kidney biopsy revealed TMA with collapsing focal segmental glomerulosclerosis (FSGS), suggesting concomitant podocyte injury. Genetic analysis identified a novel heterozygous deletion in CFHR5, resulting in a shorter-than-normal FHR5 protein, as revealed by Western blot, consistent with the predicted product of the deleted gene. Functional assays using endothelial cells demonstrated abnormal C5b-9 formation, indicating complement dysregulation. The patient achieved clinical recovery with mild residual proteinuria after plasma infusion and supportive therapy. This case highlights a potential pathogenic role of aberrant FHR5 proteins in postpartum aHUS and suggests a link between complement-mediated endothelial dysfunction and podocyte injury in TMA with collapsing FSGS. Complement genetic and functional testing should be considered in postpartum TMA, even in the absence of overt complement consumption, to guide diagnosis, prognosis, and treatment.
Thrombotic microangiopathies (TMAs) that occur during pregnancy or the postpartum period-including preeclampsia/HELLP syndrome (hemolysis, elevated liver enzymes, low platelets), thrombotic thrombocytopenic purpura, and atypical hemolytic uremic syndrome (aHUS)-present a diagnostic challenge owing to their overlapping clinical features. We report a case of a 21-year-old primigravida of African origin who developed HELLP syndrome followed by postpartum aHUS. The clinical course was marked by thrombocytopenia, hemolytic anemia, acute kidney injury, and massive proteinuria. Kidney biopsy revealed TMA with collapsing focal segmental glomerulosclerosis (FSGS), suggesting concomitant podocyte injury. Genetic analysis identified a novel heterozygous deletion in CFHR5, resulting in a shorter-than-normal FHR5 protein, as revealed by Western blot, consistent with the predicted product of the deleted gene. Functional assays using endothelial cells demonstrated abnormal C5b-9 formation, indicating complement dysregulation. The patient achieved clinical recovery with mild residual proteinuria after plasma infusion and supportive therapy. This case highlights a potential pathogenic role of aberrant FHR5 proteins in postpartum aHUS and suggests a link between complement-mediated endothelial dysfunction and podocyte injury in TMA with collapsing FSGS. Complement genetic and functional testing should be considered in postpartum TMA, even in the absence of overt complement consumption, to guide diagnosis, prognosis, and treatment.
More Related Videos
08:22A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
Published on: December 1, 2017
09:16Array Comparative Genomic Hybridization (Array CGH) for Detection of Genomic Copy Number Variants
Published on: February 21, 2015
Related Concept Videos
Cytomegalovirus Disease
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Complement System
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
